Cite
MLA Citation
Rainard Fuhr et al.. “Results from a Phase 1/2 trial of BB2603, a terbinafine‐based topical nano‐formulation, in onychomycosis and tinea pedis.” Mycoses, vol. 65, no. 6, 2022, pp. 661–669. http://access.bl.uk/ark:/81055/vdc_100156416926.0x000047